Dual GLP-1/GIP agonist for substantial weight loss (up to ~15-20% in trials depending on dose),
improved glycemic control (enhanced insulin secretion, reduced liver glucose output), strong
appetite suppression/fullness + slowed gastric emptying, cardiometabolic benefits (reduced
waist/BP/cholesterol, fat mass), and potential OSA management/cardiovascular risk reduction.
$88.00
